Exponent, Inc. (NASDAQ:EXPO) Shares Purchased by Aviva PLC

Aviva PLC grew its stake in shares of Exponent, Inc. (NASDAQ:EXPO) by 5.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,359 shares of the business services provider’s stock after acquiring an additional 336 shares during the period. Aviva PLC’s holdings in Exponent were worth $567,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently modified their holdings of EXPO. Private Trust Co. NA grew its stake in Exponent by 129.8% in the fourth quarter. Private Trust Co. NA now owns 278 shares of the business services provider’s stock worth $25,000 after purchasing an additional 157 shares in the last quarter. Atala Financial Inc bought a new position in Exponent during the 4th quarter worth approximately $25,000. Westside Investment Management Inc. acquired a new position in shares of Exponent in the 3rd quarter worth approximately $26,000. Tortoise Investment Management LLC grew its position in shares of Exponent by 76.7% in the 4th quarter. Tortoise Investment Management LLC now owns 440 shares of the business services provider’s stock worth $39,000 after acquiring an additional 191 shares in the last quarter. Finally, Trust Co. of Vermont bought a new stake in shares of Exponent in the 4th quarter valued at approximately $45,000. Institutional investors own 92.37% of the company’s stock.

Exponent Price Performance

Shares of EXPO opened at $79.00 on Friday. The stock has a market capitalization of $4.01 billion, a PE ratio of 37.26 and a beta of 0.84. The business’s fifty day moving average price is $83.77 and its 200 day moving average price is $93.48. Exponent, Inc. has a 12-month low of $73.83 and a 12-month high of $115.75.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.40 by $0.06. Exponent had a net margin of 19.52% and a return on equity of 27.27%. During the same period in the prior year, the company posted $0.41 EPS. As a group, research analysts anticipate that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Insider Buying and Selling at Exponent

In related news, VP Richard Reiss sold 1,736 shares of the firm’s stock in a transaction that occurred on Wednesday, February 26th. The stock was sold at an average price of $85.93, for a total value of $149,174.48. Following the sale, the vice president now owns 1,800 shares of the company’s stock, valued at approximately $154,674. This trade represents a 49.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. 2.10% of the stock is currently owned by insiders.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.